Early molecular events in the hippocampus of rats with streptozotocin-induced diabetes

Neurophysiology

Volumn 39, Issue 6, 2007, Pages 435-438

  Orlovsky, M A ^a   Spiga, F ^b   Lebed, Y V ^a   Skibo, G G ^a   Lightman, S L ^b  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Bcl2protein; Diabetes mellitus; Hippocampus; Mineralocorticoid and glucocorticoid receptors; Nitric oxide synthase

Indexed keywords

CORTICOSTEROID RECEPTOR; CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DYSFUNCTION; BRAIN LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DIABETES MELLITUS; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; WISTAR RAT;

EID: 50149089365     PISSN: 00902977     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11062-008-9000-0     Document Type: Article

References (12)

1. G. J. Biessels, L. P. van der Heide, A. Kamal, et al., "Ageing and diabetes: Implications for brain function," Eur. J. Pharmacol., 441, Nos. 1/2, 1-14 (2002). 1-14 (2002).
2. G. S. Minhourt, P. Scheltens, M. Diamant, et al., "Diabetic encephalopathy: A concept in need of definition," Diabetologia, 49, 1447-1448 (2006).
3. A. M. Magarinos and B. S. McEwen, "Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress," Proc. Natl. Acad. Sci. USA, 97, 11056-11061 (2000).
4. Y. Revsin, F. Saravia, P. Roig, et al., "Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes," Brain Res., 1038, 22-31 (2005).
5. S. Amrani, M. Durant, J. Throsby, et al., "Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage," Endocrinology, 139, 1115-1124 (1998).
6. G. J. Biessels and W. H. Gispen, "The impact of diabetes on cognition: What can be learned from rodent models?" Neurobiol. Aging, 26, 36-41 (2005).
7. C. M. Ryan, "Diabetes, aging, and cognitive decline," Neurobiol. Aging, 26, 21-25 (2005).
8. P. J. Lucassen, V. M. Heine, M. B. Muller, et al., "Stress, depression and hippocampal apoptosis," CNS. Neurol. Disord. Drug Targets, 5, 531-546 (2006).
9. S. Rossie, H. Jayachandran, and R. L. Meisel, "Cellular co-localization of protein phosphatase 5 and glucocorticoid receptors in rat brain," Brain Res., 1111, 1-11 (2006).
10. R. M. Sapolsky, H. Uno, C. S. Rebert, et al., "Hippocampal damage associated with prolonged glucocorticoid exposure in primates," J. Neurosci., 10, 2897-2902 (1990).
11. L. E. Haynes, M. R. Griffiths, R. E. Hyde, et al., "Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: Implications for mood disorders," Neuroscience, 104, 57-69 (2001).
12. D. F. Swaab, A. M. Bao, and P. J. Lucassen, "The stress system in the human brain in depression and neurodegeneration," Ageing Res. Rev., 4, 141-194 (2005).